Access. Intelligence. Excellence

Advanced Search

Home > Products & Services > Benchmarking Reports > Medical Affairs > Patient Advocacy

Patient-Focused Support: How Government Affairs & Public Policy Groups Support the Patient Journey

Features:

8	Info Graphics
12	Data Graphics
100	Metrics
3	Narratives

Pages: 31

Delivery Format: Shipped

Call 919-403-0251

ID: PSM-307

Price:

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.

Patient advocacy is a critical success factor in the health care industry. Government Affairs and Public Policy functions provide various patient support programs and initiatives designed to engage patients.

Best Practices, LLC undertook this research study to capture industry metrics on the level and type of support that Government Affairs and Public Policy functions provide to positively impact the patient journey. The study includes leading insights and metrics around the activities, timing and funding contribution of Government Affairs and Public Policy groups towards patient advocacy and awareness.

Benchmark Class
Study Snapshot
Key Findings
View TOC and List of Exhibits

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Chemical; Technology; Diagnostic; Medical Device

Companies Profiled:
Boehringer Ingelheim; Dr Reddy's Laboratories; GlaxoSmithKline ; Shire; Abbvie; Teva Pharmaceutical Industries Ltd; Sanofi; BD; UCB Pharma; Astellas; Janssen; AstraZeneca; Abbott; Genentech; Roche

Study Snapshot

Sixteen survey respondents from 15 companies participated in this study. The majority of study participants worked either at the director, senior director or vice president level. Almost all study participants worked in either Government Affairs or Public Policy roles.

Key topics include:

Patient-Focused Support: Activities & Timing

Scope
Number of Product Supported
Activities
Timing by Phase

Patient-Focused Support: Funding

Investment by Function
Investment Trends
Investment Levels

Key Findings

Partnering with patient advocacy groups is most common engagement activity: Partnering with patient advocacy groups occurs at 87% of benchmarked organizations, while 67% are also active in community outreach programs (e.g., screening events), and influencing payer & federal disease policy.

Table of Contents

Executive Summary� � pp. 3-4�

Research Overview� pp. 4
Participating Companies ��pp. 5-6

Key Findings� pp. 7-10
Patient-Focused Support: �Activities & Timing� pp. 11-22
Patient-Focused Support: �Funding�� pp. 23-30
About Best Practices, LLC� � pp. 31

List of Charts & Exhibits

Functional area represented by benchmark partners

Type of products for which Gov't Affairs/Public Policy (GA/PP) groups conduct patient engagement activities
Therapeutic areas represented by the Gov't Affairs/Public Policy groups
Number of products/brands supported by GA/PP groups
The 6 phases of the patient journey
Patient engagement activities and programs conducted by GA/PP groups
GA/PP patient engagement activities timing by patient journey phase
Investment level into engagement activities by patient journey phase
GA/PP patient engagement – Best Practices
Patient engagement activities funding from GA/PP function
% allocation of total GA/PP budget to patient engagement activities
Total GA/PP patient engagement investment
Functions/Groups investing in patient engagement activities

Related Research

Best Practices in Working with Patient Advocacy Groups: Building Effective Relationships

Patient and professional advocacy groups play a crucial role in educating the marketplace on new medicines and treatments... (ID SM-185)
Companies Profiled: Abaxis, Abbott Laboratories, Allos Therapeutics, Amgen, read more ...

Price: $7500.00 Free Excerpt Available

Collaborating with Patient Advocacy Groups to Educate the Marketplace

Strong relationships with advocacy groups are fundamental for educating the public on most recent medical happenings, especially on socially-sensitive conditions and treatment options... (ID PSM-242)
Companies Profiled: Abbott Laboratories, Baxter Healthcare, Solvay Pharmaceuticals, Vital Therapies, read more ...

Price: $6500.00 Free Excerpt Available

Medical Affairs' Role in Patient Engagement Activities

The medical affairs function continues its evolution from a support-only function into an independent role, one that is critical to the success of pharmaceutical companies... (ID POP-280)
Companies Profiled: Abbvie, Actelion, Alkermes, AstraZeneca, read more ...

Price: $5800.00 Free Excerpt Available

Advocacy Excellence: Optimizing Group Structure & Operations

Alliances with patient advocacy groups play an important role in educating the marketplace about new and existing therapies... (ID PSM-253)
Companies Profiled: Abbott, Genomic Health, Boehringer Ingelheim, Amgen, read more ...

Price: $5100.00 Free Excerpt Available

Collaborating with Patient Advocacy Groups to Educate the Marketplace

Patient and Professional Advocacy Groups are an important part of the process by which the marketplace is educated on new medicines and treatments... (ID PSM-330)
Companies Profiled: Alnylam Pharmaceuticals, Astellas, Baldwin Area Medical Center, Bayer, read more ...

Price: $4000.00 Free Excerpt Available

Soliris: Translating Groundbreaking Science into a Successful Orphan Drug

The only FDA approved treatment for life-threatening ultra-rare disorders - paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), Soliris (eculizumab) - developed by Alexion Pharmaceuticals, gained substantial benefits from its orphan drug status, clinical effectiveness and first-to-market status... (ID PSM-342)
Companies Profiled: Alexion Pharmaceuticals, Epirus Biopharmaceuticals, Amgen

Price: $2500.00 Free Excerpt Available

ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE

Quick Links